O’Keeffe M, Booker SA, Walsh D, Li M, Henley C, Simões de Oliveira L, Liu M, Wang X, Banqueri M, Ridley Okay, et al. Typical improvement of synaptic and neuronal properties can proceed with out microglia within the cortex and thalamus. Nat Neurosci. 2025;28(2):268–79.
Baligács N, Albertini G, Borrie SC, Serneels L, Pridans C, Balusu S, De Strooper B. Homeostatic microglia initially seed and activated microglia later reshape amyloid plaques in Alzheimer’s illness. Nat Commun. 2024;15(1):10634.
Geloso MC, Zupo L, Corvino V. Crosstalk between peripheral irritation and mind: deal with the responses of microglia and astrocytes to peripheral problem. Neurochem Int. 2024;180:105872.
Bernier LP, York EM, MacVicar BA. Immunometabolism within the mind: how metabolism shapes microglial perform. Traits Neurosci. 2020;43(11):854–69.
Solar N, Victor MB, Park YP, Xiong X, Scannail AN, Leary N, Prosper S, Viswanathan S, Luna X, Boix CA, et al. Human microglial state dynamics in Alzheimer’s illness development. Cell. 2023;186(20):4386–e44034329.
Xu X, He Y, Liu J, Berberine. A multifaceted agent for lung most cancers treatment-from molecular perception to scientific purposes. Gene. 2025;934:149021.
Jiang Y-J, Cheng Y-H, Zhu H-Q, Wu Y-L, Nan J-X, Lian L-H. Palmatine, an isoquinoline alkaloid from Phellodendron amurense Rupr., ameliorated gouty irritation by inhibiting pyroptosis by way of NLRP3 inflammasome. J Ethnopharmacol. 2025;340:119231.
Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood–mind barrier: construction, regulation and drug supply. Sign Transduct Goal Ther. 2023;8(1):217.
Li X, Zou J, He Z, Solar Y, Track X, He W. The interplay between particles and vascular endothelium in blood circulation. Adv Drug Del Rev. 2024;207:115216.
Ashique S, Pal R, Sharma H, Mishra N, Garg A. Unraveling the rising area of interest position of extracellular vesicles (EVs) in traumatic mind damage (TBI). CNS Neurol Disord Drug Targets. 2024;23(11):1357–70.
Wang P, Wang Y, Li P, Chen C, Ma S, Zhao L, He H, Yin T, Zhang Y, Tang X, Gou J. Oral supply of polyester nanoparticles for brain-targeting: challenges and alternatives. Chin Chem Lett. 2023;34(4):107691.
Yang Z, Shi J, Xie J, Wang Y, Solar J, Liu T, Zhao Y, Zhao X, Wang X, Ma Y, et al. Giant-scale era of purposeful mRNA-encapsulating exosomes by way of mobile nanoporation. Nat Biomed Eng. 2020;4(1):69–83.
Soltanmohammadi F, Gharehbaba AM, Zangi AR, Adibkia Okay, Javadzadeh Y. Present data of hybrid nanoplatforms composed of exosomes and natural/inorganic nanoparticles for illness remedy and cell/tissue imaging. Biomed Pharmacother. 2024;178:117248.
Palakurthi SS, Shah B, Kapre S, Charbe N, Immanuel S, Pasham S, Thalla M, Jain A, Palakurthi S. A complete evaluation of challenges and advances in exosome-based drug supply methods. Nanoscale Adv. 2024;6(23):5803–26.
Track X, Gu L, Yang Q, Wu J, Chen J, Tian X, Solar L, Chen L. Thermosensitive injectable hydrogel loaded with hypoxia-induced exosomes maintains chondrocyte phenotype by NDRG3-mediated hypoxic response. Chin Chem Lett. 2023;34(8):108079.
Xiao Q, Li X, Liu C, Yang Y, Hou Y, Wang Y, Su M, He W. Liposome-based anchoring and core-encapsulation for combinatorial most cancers remedy. Chin Chem Lett. 2022;33(9):4191–6.
Xiao Q, Li X, Liu C, Jiang Y, He Y, Zhang W, Azevedo HS, Wu W, Xia Y, He W. Enhancing most cancers immunotherapy by way of co-delivering checkpoint Blockade and thrombospondin-1 downregulator. Acta Pharm Sin B. 2023;13(8):3503–17.
Yuan J, Guo M, Zhao S, Li J, Wang X, Yang J, Jin Z, Track X. Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide. Chin Chem Lett. 2023;34(4):107943.
Wang T, Fu Y, Solar S, Huang C, Yi Y, Wang J, Deng Y, Wu M. Exosome-based drug supply methods in most cancers remedy. Chin Chem Lett. 2023;34(2):107508.
Hao X, Gan J, Cao J, Zhang D, Liang J, Solar L. Biomimetic liposomes hybrid with erythrocyte membrane modulate dendritic cells to ameliorate systemic lupus erythematosus. Mater Right this moment Bio. 2023;20:100625.
Geng T, Tang M, Yee Paek S, Leung E, Chamley LW, Wu Z. A easy method to re-engineering small extracellular vesicles to bypass endosome entrapment. Int J Pharm. 2022;626:122153.
Sharma H, Rachamalla HK, Mishra N, Chandra P, Pathak R, Ashique S. Introduction to exosome and its position in mind issues. Singapore: Springer; 2024.
Kumar P, Sharma H, Singh A, Pandey SN, Chandra P. Correlation between exosomes and Neuro-inflammation in numerous mind issues. Singapore: Springer; 2024.
Sharma H, Anand A, Halagali P, Inamdar A, Pathak R, Taghizadeh-Hesary F, Ashique S. Position of flavonoids in continual metabolic ailments. Scrivener Publishing; 2024.
Sharma H, Tyagi SJ, Chandra P, Verma A, Kumar P, Ashique S, Hussain A. Exosomes primarily based drug supply methods for mind issues. Singapore: Springer; 2024.
Liu Y, Zhu M, Meng M, Wang Q, Wang Y, Lei Y, Zhang Y, Weng L, Chen X. A dual-responsive hyaluronic acid nanocomposite hydrogel drug supply system for overcoming a number of drug resistance. Chin Chem Lett. 2023;34(1):107583.
Zhu H, Yu J, Ye J, Wu Y, Pan J, Li Y, Chen C, Zheng L, Liu G, Chu C. Nanoparticle-mediated corneal neovascularization therapies: towards new era of drug supply methods. Chin Chem Lett. 2023;34(3):107648.
Wang X, Chen S, Xia X, Du Y, Wei Y, Yang W, Zhang Y, Track Y, Lei T, Huang Q, Gao H. Lysosome-Concentrating on protein degradation by endocytosis pathway triggered by polyvalent Nano-Chimera for AD remedy. Adv Mater. 2025;37(5):e2411061.
Zare D, Rajizadeh MA, Maneshian M, Jonaidi H, Sheibani V, Asadi-Shekaari M, Yousefi M, Esmaeilpour Okay. Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive efficiency and synaptic plasticity impairments in animal mannequin of Alzheimer’s ailments. Psychopharmacology. 2021;238(6):1645–56.
Yan XS, Yang ZJ, Jia JX, Track W, Fang X, Cai ZP, Huo DS, Wang H. Protecting mechanism of testosterone on cognitive impairment in a rat mannequin of Alzheimer’s illness. Neural Regen Res. 2019;14(4):649–57.
Kapoor KS, Harris Okay, Arian KA, Ma L, Schueng Zancanela B, Church KA, McAndrews KM, Kalluri R. Excessive throughput and fast isolation of extracellular vesicles and exosomes with purity utilizing measurement exclusion liquid chromatography. Bioact Mater. 2024;40:683–95.
Takov Okay, Yellon DM, Davidson SM. Comparability of small extracellular vesicles remoted from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and purposeful potential. J Extracell Vesicles. 2019;8(1):1560809.
Li W, Li C, Zhou T, Liu X, Liu X, Li X, Chen D. Position of Exosomal proteins in most cancers prognosis. Mol Most cancers. 2017;16(1):145.
Fernandes M, Lopes I, Magalhaes L, Sarria MP, Machado R, Sousa JC, Botelho C, Teixeira J, Gomes AC. Novel idea of exosome-like liposomes for the remedy of Alzheimer’s illness. J Management Launch. 2021;336:130–43.
Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and supply automobiles throughout organic membranes: present views and future challenges. Acta Pharm Sin B. 2016;6(4):287–96.
Mondal J, Pillarisetti S, Junnuthula V, Saha M, Hwang SR, Park IK, Lee YK. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic purposes. J Management Launch. 2023;353:1127–49.
Mukherjee A, Bisht B, Dutta S, Paul MK. Present advances in the usage of exosomes, liposomes, and bioengineered hybrid nanovesicles in most cancers detection and remedy. Acta Pharmacol Sin. 2022;43(11):2759–76.
Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, Hu XB, Xiang DX. Synthetic exosomes for translational nanomedicine. J Nanobiotechnol. 2021;19(1):242.
Piffoux M, Silva AKA, Wilhelm C, Gazeau F, Tareste D. Modification of extracellular vesicles by fusion with liposomes for the design of customized biogenic drug supply methods. ACS Nano. 2018;12(7):6830–42.
Lv Q, Cheng L, Lu Y, Zhang X, Wang Y, Deng J, Zhou J, Liu B, Liu J. Thermosensitive Exosome-Liposome hybrid Nanoparticle-Mediated chemoimmunotherapy for improved remedy of metastatic peritoneal Most cancers. Adv Sci (Weinh). 2020;7(18):2000515.
Lebreton V, Kaeokhamloed N, Vasylaki A, Hilairet G, Mellinger A, Béjaud J, Saulnier P, Lagarce F, Gattacceca F, Legeay S, Roger E. Pharmacokinetics of intact lipid nanocapsules utilizing new quantitative FRET method. J Managed Launch. 2022;351:681–91.
Chen T, He B, Tao J, He Y, Deng H, Wang X, Zheng Y. Utility of Förster resonance power switch (FRET) method to elucidate intracellular and in vivo biofate of nanomedicines. Adv Drug Del Rev. 2019;143:177–205.
Zhang H, Pan Y, Li Y, Tang C, Xu Z, Li C, Xu F, Mai Y. Hybrid polymer vesicles: controllable Preparation and potential purposes. Biomacromolecules. 2023;24(9):3929–53.
Moholkar DN, Kandimalla R, Gupta RC, Aqil F. Advances in lipid-based carriers for most cancers therapeutics: liposomes, exosomes and hybrid exosomes. Most cancers Lett. 2023;565:216220.
Ashby G, Keng KE, Hayden CC, Gollapudi S, Houser JR, Jamal S, Stachowiak JC. Selective endocytic uptake of focused liposomes happens inside a slim vary of liposome diameters. ACS Appl Mater Interfaces. 2023;15(43):49988–50001.
Gandek TB, van der Koog L, Nagelkerke A. A comparability of mobile uptake mechanisms, supply efficacy, and intracellular destiny between liposomes and extracellular vesicles. Adv Healthc Mater. 2023;12(25):e2300319.
Samson LD. A goal to suppress irritation. Science. 2018;362(6416):748–9.
Hurtley SM. A microglia sort related to AD. Science. 2017;357(6347):160–1.
Ji Z, Liu C, Zhao W, Soto C, Zhou X. Multi-scale modeling for systematically Understanding the important thing roles of microglia in AD improvement. Comput Biol Med. 2021;133:104374.
Sayed FA, Kodama L, Fan L, Carling GK, Udeochu JC, Le D, Li Q, Zhou L, Wong MY, Horowitz R, et al. AD-linked R47H-TREM2 mutation induces disease-enhancing microglial States by way of AKT hyperactivation. Sci Transl Med. 2021;13(622):eabe3947.
Leng F, Edison P. Neuroinflammation and microglial activation in alzheimer illness: the place will we go from right here? Nat Rev Neurol. 2021;17(3):157–72.
Wei Y, Solar Y, Wei J, Qiu X, Meng F, Storm G, Zhong Z. Selective transferrin coating as a facile technique to fabricate BBB-permeable and focused vesicles for potent RNAi remedy of mind metastatic breast most cancers in vivo. J Managed Launch. 2021;337:521–9.
Shimbo T, Kawachi M, Saga Okay, Fujita H, Yamazaki T, Tamai Okay, Kaneda Y. Growth of a transferrin receptor-targeting HVJ-E vector. Biochem Biophys Res Commun. 2007;364(3):423–8.
Goswami U, Dutta A, Raza A, Kandimalla R, Kalita S, Ghosh SS, Chattopadhyay A. Transferrin-Copper Nanocluster-Doxorubicin nanoparticles as focused theranostic Most cancers nanodrug. ACS Appl Mater Interfaces. 2018;10(4):3282–94.
Fan Okay, Zhou M, Yan X. Questions on horse spleen ferritin crossing the blood mind barrier by way of mouse transferrin receptor 1. Protein Cell. 2017;8(11):788–90.
Tomatis F, Rosa S, Simões S, Barão M, Jesus C, Novo J, Barth E, Marz M, Ferreira L. Engineering extracellular vesicles to transiently permeabilize the blood–mind barrier. J Nanobiotechnol. 2024;22(1):747.
Liu D, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, Huan M, Zhou S. Cyclosporine A loaded mind concentrating on nanoparticle to deal with cerebral ischemia/reperfusion damage in mice. J Nanobiotechnol. 2022;20(1):256.
Zhou Y, Zhou W, Chen X, Wang Q, Li C, Chen Q, Zhang Y, Lu Y, Ding X, Jiang C. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and focused chemotherapy of pancreatic most cancers. Acta Pharm Sin B. 2020;10(8):1563–75.
Kafa H, Wang JT, Rubio N, Klippstein R, Costa PM, Hassan HA, Sosabowski JK, Bansal SS, Preston JE, Abbott NJ, Al-Jamal KT. Translocation of LRP1 focused carbon nanotubes of various diameters throughout the blood-brain barrier in vitro and in vivo. J Management Launch. 2016;225:217–29.
Xu M, Soliman MG, Solar X, Pelaz B, Feliu N, Parak WJ, Liu S. How entanglement of various physicochemical properties complicates the prediction of in vitro and in vivo interactions of gold nanoparticles. ACS Nano. 2018;12(10):10104–13.
Sonali, Singh RP, Singh N, Sharma G, Vijayakumar MR, Koch B, Singh S, Singh U, Sprint D, Pandey BL, Muthu MS. Transferrin liposomes of docetaxel for brain-targeted most cancers purposes: formulation and mind theranostics. Drug Deliv. 2016;23(4):1261–71.
Gopalan D, Pandey A, Udupa N, Mutalik S. Receptor particular, stimuli responsive and subcellular focused approaches for efficient remedy of Alzheimer: position of floor engineered nanocarriers. J Management Launch. 2020;319:183–200.
Wan M, Solar S, Di X, Zhao M, Lu F, Zhang Z, Li Y. Icariin improves studying and reminiscence perform in Abeta(1–42)-induced AD mice by regulation of the BDNF-TrkappaB signaling pathway. J Ethnopharmacol. 2024;318(Pt B):117029.
Bolmont T, Clavaguera F, Meyer-Luehmann M, Herzig MC, Radde R, Staufenbiel M, Lewis J, Hutton M, Tolnay M, Jucker M. Induction of Tau pathology by intracerebral infusion of amyloid-beta -containing mind extract and by amyloid-beta deposition in APP X Tau Transgenic mice. Am J Pathol. 2007;171(6):2012–20.
Hour FQ, Moghadam AJ, Shakeri-Zadeh A, Bakhtiyari M, Shabani R, Mehdizadeh M. Magnetic focused supply of the SPIONs-labeled mesenchymal stem cells derived from human Wharton’s jelly in Alzheimer’s rat fashions. J Management Launch. 2020;321:430–41.
Chen Q, Du Y, Zhang Okay, Liang Z, Li J, Yu H, Ren R, Feng J, Jin Z, Li F, et al. Tau-Focused multifunctional nanocomposite for combinational remedy of Alzheimer’s illness. ACS Nano. 2018;12(2):1321–38.
Shi Y, Huang W, Wang Y, Zhang R, Hou L, Xu J, Qiu Z, Xie Q, Chen H, Zhang Y, Wang H. Bis(9)-(-)-Meptazinol, a novel dual-binding ache inhibitor, rescues cognitive deficits and pathological modifications in APP/PS1 Transgenic mice. Transl Neurodegener. 2018;7:21.
Qi YY, Heng X, Yao ZY, Qu SY, Ge PY, Zhao X, Ni SJ, Guo R, Yang NY, Zhang QC, Zhu HX. Involvement of Huanglian Jiedu Decoction on microglia with irregular sphingolipid metabolism in Alzheimer’s illness. Drug Des Devel Ther. 2022;16:931–50.
Zeng J, Pei H, Wu H, Chen W, Du R, He Z. Palmatine attenuates LPS-induced neuroinflammation by the PI3K/Akt/NF-kappaB pathway. J Biochem Mol Toxicol. 2024;38(1):e23544.
Xu Y, Shen B, Pan X, Liu C, Wang Y, Chen X, Wang T, Chen G, Chen J. Palmatine ameliorated lipopolysaccharide-induced sepsis-associated encephalopathy mice by regulating the microbiota-gut-brain axis. Phytomedicine. 2024;124:155307.
Wang Okay, Yin J, Chen J, Ma J, Si H, Xia D. Inhibition of irritation by Berberine: molecular mechanism and community Pharmacology evaluation. Phytomedicine. 2024;128:155258.
Zhu Okay, Yao Y, Wang Okay, Shao F, Zhu Z, Track Y, Zhou Z, Jiang D, Lan X, Qin C. Berberin sustained-release nanoparticles have been enriched in infarcted rat myocardium and resolved irritation. J Nanobiotechnol. 2023;21(1):33.
Xia Y, Wang X, Lin S, Dong TTX, Tsim KWK. Berberine and palmatine, appearing as allosteric potential ligands of alpha7 nAChR, synergistically regulate irritation and phagocytosis of microglial cells. FASEB J. 2024;38(19):e70094.
Ding MR, Qu YJ, Hu B, An HM. Sign pathways within the remedy of Alzheimer’s illness with conventional Chinese language drugs. Biomed Pharmacother. 2022;152:113208.
Durairajan SSK, Iyaswamy A, Shetty SG, Kammella AK, Malampati S, Shang W, Yang C, Track J, Chung S, Huang J, et al. A modified formulation of Huanglian-Jie-Du-Tang reduces reminiscence impairments and beta-amyloid plaques in a triple Transgenic mouse mannequin of Alzheimer’s illness. Sci Rep. 2017;7(1):6238.
Iyaswamy A, Wang X, Krishnamoorthi S, Kaliamoorthy V, Sreenivasmurthy SG, Kumar Durairajan SS, Track JX, Tong BC, Zhu Z, Su CF, et al. Theranostic F-SLOH mitigates Alzheimer’s illness pathology involving TFEB and ameliorates cognitive capabilities in Alzheimer’s illness fashions. Redox Biol. 2022;51:102280.
Starling S. Alzheimer illness: Blood-derived Abeta induces AD pathology. Nat Rev Neurol. 2018;14(1):2.
Bettcher BM, Tansey MG, Dorothee G, Heneka MT. Peripheral and central immune system crosstalk in alzheimer illness – a analysis prospectus. Nat Rev Neurol. 2021;17(11):689–701.
Yang F, Zhao Okay, Zhang X, Zhang J, Xu B. ATP induces disruption of tight junction proteins by way of IL-1 Beta-Dependent MMP-9 activation of human Blood-Mind barrier in vitro. Neural Plast. 2016;2016:8928530.
Botella Lucena P, Heneka MT. Inflammatory facets of Alzheimer’s illness. Acta Neuropathol. 2024;148(1):31.
Heneka MT, van der Flier WM, Jessen F, Hoozemanns J, Thal DR, Boche D, Brosseron F, Teunissen C, Zetterberg H, Jacobs AH et al. Neuroinflammation in alzheimer illness. Nat Rev Immunol. 2024.
Xu C, Wu J, Wu Y, Ren Z, Yao Y, Chen G, Fang EF, Noh JH, Liu YU, Wei L, et al. TNF-alpha-dependent neuronal necroptosis regulated in Alzheimer’s illness by coordination of RIPK1-p62 complicated with autophagic UVRAG. Theranostics. 2021;11(19):9452–69.
Asby D, Boche D, Allan S, Love S, Miners JS. Systemic an infection exacerbates cerebrovascular dysfunction in Alzheimer’s illness. Mind. 2021;144(6):1869–83.
Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer’s illness. J Cell Biol. 2018;217(2):459–72.
Xiao T, Yu X, Yang L, Duan X. Palmatine treats urticaria by decreasing irritation and rising autophagy. Entrance Immunol. 2023;14:1268467.
Lin X, Zhang N, Berberine. Pathways to guard neurons. Phytother Res. 2018;32(8):1501–10.
Liu T, Zhang L, Joo D, Solar SC. NF-kappaB signaling in irritation. Sign Transduct Goal Ther. 2017;2:17023.
Lingappan Okay. NF-kappaB in oxidative stress. Curr Opin Toxicol. 2018;7:81–6.
Sharma H, Chandra P, Challenges, Prospects F. A benefaction of phytoconstituents on molecular targets pertaining to Alzheimer’s illness. Int J Pharm Investig. 2023;14(1):117–26.
Solar SC. The non-canonical NF-kappaB pathway in immunity and irritation. Nat Rev Immunol. 2017;17(9):545–58.
Cao M, Day AM, Galler M, Latimer HR, Byrne DP, Foy TW, Dwyer E, Bennett E, Palmer J, Morgan BA, et al. A peroxiredoxin-P38 MAPK scaffold will increase MAPK exercise by MAP3K-independent mechanisms. Mol Cell. 2023;83(17):3140–e31543147.
Leng Okay, Li E, Eser R, Piergies A, Sit R, Tan M, Neff N, Li SH, Rodriguez RD, Suemoto CK, et al. Molecular characterization of selectively weak neurons in Alzheimer’s illness. Nat Neurosci. 2021;24(2):276–87.
Howard R, Kales HC. New therapies for Alzheimer’s illness. BMJ. 2023;382:1852.
Henstridge CM, Hyman BT, Spires-Jones TL. Past the neuron-cellular interactions early in alzheimer illness pathogenesis. Nat Rev Neurosci. 2019;20(2):94–108.
Zhao X, Ge P, Lei S, Guo S, Zhou P, Zhao L, Qi Y, Wei X, Wu W, Wang N, et al. An Exosome-Based mostly therapeutic technique concentrating on neuroinflammation in Alzheimer’s illness with Berberine and palmatine. Drug Des Devel Ther. 2023;17:2401–20.
Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL. Synaptic degeneration in alzheimer illness. Nat Rev Neurol. 2023;19(1):19–38.
Zhou X, Miao Y, Wang Y, He S, Guo L, Mao J, Chen M, Yang Y, Zhang X, Gan Y. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles improve SiRNA supply by tumour-homing and intracellular freeway transportation. J Extracell Vesicles. 2022;11(3):e12198.
Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, Gong Okay, Liu F, Duan Y, Li H. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian most cancers. J Nanobiotechnol. 2022;20(1):50.
Kawabata H. Transferrin and transferrin receptors replace. Free Radic Biol Med. 2019;133:46–54.
Bassil R, Shields Okay, Granger Okay, Zein I, Ng S, Chih B. Improved modeling of human AD with an automatic culturing platform for iPSC neurons, astrocytes and microglia. Nat Commun. 2021;12(1):5220.
Track Y, Li Z, He T, Qu M, Jiang L, Li W, Shi X, Pan J, Zhang L, Wang Y, et al. M2 microglia-derived exosomes defend the mouse mind from ischemia-reperfusion damage by way of Exosomal miR-124. Theranostics. 2019;9(10):2910–23.
Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, Liebler DC, Ping J, Liu Q, Evans R, et al. Reassessment Exosome Composition Cell. 2019;177(2):428–e445418.
Xiao T, Zhang W, Jiao B, Pan CZ, Liu X, Shen L. The position of exosomes within the pathogenesis of Alzheimer’ illness. Transl Neurodegener. 2017;6:3.
Cui J, Wang X, Li J, Zhu A, Du Y, Zeng W, Guo Y, Di L, Wang R. Immune exosomes loading Self-Assembled nanomicelles traverse the Blood-Mind barrier for Chemo-immunotherapy towards glioblastoma. ACS Nano. 2023.
Sharma H, Rani T, Khan S. An perception into neuropathic ache: A systemic and Up-to-date evaluation. Int J Pharm Sci. 2023;14(2):607–21.
Imenshahidi M, Hosseinzadeh H. Berberine and barberry (Berberis vulgaris): A scientific evaluation. Phytother Res. 2019;33(3):504–23.
Ekeuku SO, Pang KL, Chin KY. Palmatine as an agent towards metabolic syndrome and its associated issues: A evaluation. Drug Des Devel Ther. 2020;14:4963–74.
Halagali P, Inamdar A, Singh J, Anand A, Sadhu P, Pathak R, Sharma H, Biswas D. Phytochemicals, natural extracts, and dietary dietary supplements for metabolic illness administration. Endocr Metab Immune Disord Drug Targets; 2024.
Wang Y, Pei H, Chen W, Du R, Li J, He Z. Palmatine protects PC12 cells and mice from Abeta25-35-Induced oxidative stress and neuroinflammation by way of the Nrf2/HO-1 pathway. Molecules. 2023; 28(24).
Cheng Z, Kang C, Che S, Su J, Solar Q, Ge T, Guo Y, Lv J, Solar Z, Yang W, et al. Berberine: A promising remedy for neurodegenerative ailments. Entrance Pharmacol. 2022;13:845591.
Akbar M, Shabbir A, Rehman Okay, Akash MSH, Shah MA. Neuroprotective potential of Berberine in modulating Alzheimer’s illness by way of a number of signaling pathways. J Meals Biochem. 2021;45(10):e13936.
Kapoor DU, Sharma H, Maheshwari R, Pareek A, Gaur M, Prajapati BG, Castro GR, Thanawuth Okay, Suttiruengwong S, Sriamornsak P. Konjac Glucomannan: A complete evaluation of its extraction, well being advantages, and pharmaceutical purposes. Carbohydr Polym. 2024;339:122266.
Cummings J. Anti-Amyloid monoclonal antibodies are transformative therapies that redefine Alzheimer’s illness therapeutics. Medicine. 2023;83(7):569–76.
Gehlot P, Pathak R, Kumar S, Choudhary NK, Vyas VK. A evaluation on artificial inhibitors of dual-specific tyrosine phosphorylation-regulated kinase 1A (DYRK1A) for the remedy of Alzheimer’s illness (AD). Bioorg Med Chem. 2024;113:117925.
Chandra P, Sharma H. Phosphodiesterase inhibitors for remedy of Alzheimer’s illness. Indian Medicine. 2024;61:7.
Sharma H, Chandra P, Verma A, Pandey S, Kumar P, Singh A. Therapeutic approaches of nutraceuticals within the prevention of Alzheimer’s illness. J Meals Biochem. 2023;46(12):e14426.
Zhu S, Stein Richard A, Yoshioka C, Lee C-H, Goehring A, McHaourab Hassane S, Gouaux E. Mechanism of NMDA receptor Inhibition and activation. Cell. 2016;165(3):704–14.
Wang Y, Tong Q, Ma SR, Zhao ZX, Pan LB, Cong L, Han P, Peng R, Yu H, Lin Y, et al. Oral Berberine improves mind dopa/dopamine ranges to ameliorate Parkinson’s illness by regulating intestine microbiota. Sign Transduct Goal Ther. 2021;6(1):77.
Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G. Amyotrophic lateral sclerosis. Lancet. 2022;400(10360):1363–80.
Christoforidou E, Joilin G, Hafezparast M. Potential of activated microglia as a supply of dysregulated extracellular MicroRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis. J Neuroinflammation. 2020;17(1):135.
Himanshu S, Monika Okay, Priyanka G, Sanakattula S, Ananya C, Sumel A, Radheshyam P. Position of MiRNAs in mind improvement. MicroRNA. 2024;13(2):96–109.
Kam TI, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in Parkinson’s illness. Neurobiol Dis. 2020;144:105028.
